1Lun·

BREAKING: TRUMP HAS TAKEN ACTION AGAINST THE PHARMACEUTICAL INDUSTRY

33
50 Comentarios

Imagen de perfil
someone wants to strike in the pharma sector 🥸
21
Ver todas las 2 respuestas adicionales
Imagen de perfil
I think I'll only invest in ETFs.... nobody can stand that.
9
Ver todas las 8 respuestas adicionales
Imagen de perfil
🍊 They're probably lowering the Novo price again.
Then I'll soon be able to buy it too. 🙈
8
Ver todas las 9 respuestas adicionales
Keep calm. Today's losers will be tomorrow's winners. Nothing will change in this respect.
6
Imagen de perfil
@market_expert_gbtws I also see it more as an opportunity ✌️
1
Imagen de perfil
What's all this crap again? 🤦🏼‍♂️ What else is to come in the next 4 years ?
4
Imagen de perfil
@Aktienhauptmeister He has already done so much that it's enough for 2 terms in office 😂
3
Imagen de perfil
@BamBamInvest 4 years and he causes level 11 earthquakes and tsunami waves higher than Mount Everest within a very short time. It is officially the BOAT (worst of all time) 😂
3
Imagen de perfil
Oh dear, my limit buy order from $NOVO B at 35 will probably be triggered after all 😬
2
Imagen de perfil
@Imperial_Trading_Company would be great 😂
1
Imagen de perfil
Let's see what comes out of it 🤣 I'll put it this way. You have to crack the pharma lobby first
2
Imagen de perfil
@Michey777 It's true, it won't be that easy, but it's already painful to watch. The way such a large company is being run into the ground. It shows once again that anyone can be affected.
Imagen de perfil
Do you mean $NOVO B? They were largely responsible for that themselves. I think many had already expected it. If you look at the P/E development YTD, then some had already suspected something.
Imagen de perfil
Hadn't he announced extensive measures against the pharmaceutical industry in recent months? 🤔

Well, I think he thought today was a good time, after the FED once again didn't give him an interest rate cut.

Let's see how that plays out in the future. I'm looking forward to the details in these letters.
1
Imagen de perfil
@EarlyBird1607 he's just so unpredictable, but at some point it's already priced in and who knows what's really coming and what's not
Imagen de perfil
It's getting worse and worse for the industry🫠🫠both UNH and Novo are getting a lot of fat 🫠🫠🫠
1
Imagen de perfil
this isn’t about the post but why did you sell NU Holdings, there starting to dominate South America and are looking like a good growth stock to buy now
1
Imagen de perfil
@TyV my expectations were too high and I needed capital to make other investments.
Imagen de perfil
@BamBamInvest do you still think it’s a good growth stock to hold for the next 2-5 years though because it’s looking good to me, i just want your opinion since you’ve been doing this way longer than me and your more in depth
1
Imagen de perfil
@TyV you mean $NU? I find it difficult to judge, as I'm not sure whether they can maintain their high growth rate, but basically I think the company is good. It's just that they are already relatively large, there are many smaller companies that still have some growing to do.
Imagen de perfil
@BamBamInvest ah i see thanks for the time and info man you’ve been a big help on my journey to get rich
1
Imagen de perfil
@TyV very much so, could be a very difficult market phase seasonally at the moment, $NU is certainly very strongly positioned in South America and has a lot of cross-selling potential, they can also take on other segments, the question is how much they can grow beyond South America and how the battle with $MELI will end.
Imagen de perfil
It's like that meme of the Simpsons: Stop! He's already dead 😭
Imagen de perfil
don't do anything
Imagen de perfil
Does anyone have a list of who got all this? $ROG probably didn't get anything, for example.
Imagen de perfil
@Michey777 I don't think this will be the last we've heard of it here 😂
Imagen de perfil
@BamBamInvest no, certainly not. But it is by no means the case that only the pharmaceutical companies are responsible for the high prices in the USA. Some middlemen are also making money...
1
yep, I was still out of pharma before 👋
Imagen de perfil
Trump is once again using his tried-and-tested negotiating tactics, this time with Big Pharma. In the style of the well-known TACO principle: "Take A Crazy Opening" he starts with maximum pressure to get a few percent more in the end. 💥🍽️

However, there is also another interpretation of TACO: "Trump Always Chicken Out" 🐔😉 Big announcements followed by a sudden retreat. Whether he really delivers this time or just uses the stage again remains to be seen.

One thing you have to give him credit for is that he knows how to stage his negotiations like a show. But will this really result in fair drug prices in the end or was it just another clever PR move?
Imagen de perfil
Why doesn't the ped0 president publish the Epstein list?
Mostrar respuesta
Únase a la conversación